These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9723396)

  • 41. Hepatitis C infection is not associated with an increased risk of acute liver allograft rejection.
    McLaughlin K; Rizkalla KS; Adams PC; Grant DR; Wall WJ; Jevnikar AM; Marotta PJ
    Transplant Proc; 2000 Dec; 32(8):2814-6. PubMed ID: 11134814
    [No Abstract]   [Full Text] [Related]  

  • 42. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
    Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
    Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft.
    Sánchez-Fueyo A; Restrepo JC; Quintó L; Bruguera M; Grande L; Sánchez-Tapias JM; Rodés J; Rimola A
    Transplantation; 2002 Jan; 73(1):56-63. PubMed ID: 11792978
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Posttransplant malignancy and newer immunosuppressive protocols after liver transplantation.
    Jonas S; Bechstein WO; Rayes N; Neuhaus R; Guckelberger O; Tullius SG; Schmidt G; Riess H; Lobeck H; Vogl T; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3246-7. PubMed ID: 8962257
    [No Abstract]   [Full Text] [Related]  

  • 45. Use of mycophenolate mofetil in kidney transplant recipients with viral hepatitis infection: is it justified?
    Sumethkul V; Ingsathit A; Leelasa-Nguan P; Jirasiritham S
    Transplant Proc; 2002 Dec; 34(8):3217-9. PubMed ID: 12493425
    [No Abstract]   [Full Text] [Related]  

  • 46. Hepatitis B recurrence in relation to immunosuppression and acute allograft rejection.
    Platz KP; Mueller AR; Haller GW; Naumann U; Berg T; Fukomoto T; Lemmens HP; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3236-7. PubMed ID: 8962252
    [No Abstract]   [Full Text] [Related]  

  • 47. Indication for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantation.
    Platz KP; Mueller AR; Willimski C; Mansoorian B; Berg T; Neuhaus R; Hopf U; Radke C; Neuhaus P
    Transplant Proc; 1998 Aug; 30(5):2232-3. PubMed ID: 9723453
    [No Abstract]   [Full Text] [Related]  

  • 48. Impact of hepatitis B or C infection on the practice of kidney transplantation in the United States.
    Schweitzer EJ; Bartlett ST; Keay S; Hadley GA; Cregar J; Stockdreher DD
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1456-7. PubMed ID: 8442157
    [No Abstract]   [Full Text] [Related]  

  • 49. Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics, and impact on survival.
    Lunel F; Cadranel JF; Rosenheim M; Dorent R; Di-Martino V; Payan C; Fretz C; Ghoussoub JJ; Bernard B; Dumont B; Perrin M; Gandjbachkh I; Huraux JM; Stuyver L; Opolon P
    Gastroenterology; 2000 Oct; 119(4):1064-74. PubMed ID: 11040193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis C virus genotypes and severe hepatitis C virus recurrence after liver transplantation.
    Alberti AB; Belli LS; Silini E; Zavaglia C; Iamoni G; Rondinara GF; De Carlis L; Forti D; Ideo G
    Transplant Proc; 1997; 29(1-2):522-3. PubMed ID: 9123114
    [No Abstract]   [Full Text] [Related]  

  • 51. Indications for determination of alpha-glutathione-s-transferase after liver transplantation.
    Platz KP; Mueller AR; Müller C; Wenig M; Schumacher G; Steinmüller T; Köttgen E; Neuhaus P
    Transplant Proc; 1999; 31(1-2):462-4. PubMed ID: 10083191
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-term outcome after liver transplantation in Egyptians transplanted for hepatitis C virus cirrhosis.
    Khalaf H
    Transplant Proc; 2003 Nov; 35(7):2777-8. PubMed ID: 14612116
    [No Abstract]   [Full Text] [Related]  

  • 53. Eleven-year experience of kidney transplantation in patients with hepatitis B and C infection.
    Sumethkul V; Jirakranont B; Jirasiritham S; Pairoj W
    Transplant Proc; 2000 Nov; 32(7):1944-5. PubMed ID: 11120012
    [No Abstract]   [Full Text] [Related]  

  • 54. Long-term evolution of anti-HCV-positive renal transplant recipients.
    Aroldi A; Lampertico P; Elli A; Lunghi G; Tarantino A; Montagnino G; Colombo M; Ponticelli C
    Transplant Proc; 1998 Aug; 30(5):2076-8. PubMed ID: 9723397
    [No Abstract]   [Full Text] [Related]  

  • 55. Liver transplantation for fulminant hepatic failure caused by viral infections.
    Raakow R; Blumhardt G; Bechstein WO; Keck H; Kling N; Langrehr JM; Neuhaus P
    Transplant Proc; 1994 Dec; 26(6):3606-7. PubMed ID: 7998289
    [No Abstract]   [Full Text] [Related]  

  • 56. Absence of initial viral replication and long-term high dose immunoglobulin administration improve results of hepatitis B virus recurrence prophylaxis after liver transplantation.
    Gugenheim J; Baldini E; Ouzan D; Mouiel J
    Transplant Proc; 1997; 29(1-2):517-8. PubMed ID: 9123112
    [No Abstract]   [Full Text] [Related]  

  • 57. [Evaluation of results of liver transplantation: experience based on a series of 1052 transplantations].
    Bismuth H; Farges O; Castaing D; Samuel D; Adam R; Johann M; Azoulay D; Feray C; Astarcioglu I; Saliba F
    Presse Med; 1995 Jul 1-8; 24(24):1106-14. PubMed ID: 7567817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Viral hepatitis after liver transplantation. Which immunosuppressive drugs should be recommended?
    Ciesek S; Manns MP; Wedemeyer H
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):337-50. PubMed ID: 18043552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. BK virus in liver transplant recipients: a prospective study.
    Loeches B; Valerio M; Pérez M; Bañares R; Ledesma J; Fogeda M; Salcedo M; Rincón D; Bouza E; Muñoz P;
    Transplant Proc; 2009 Apr; 41(3):1033-7. PubMed ID: 19376419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Liver transplantation in patients with hepatitis B virus, hepatitis C virus, or human immunodeficiency virus].
    Duclos-Vallée JC; Roche B; Samuel D
    Presse Med; 2009 Sep; 38(9):1281-9. PubMed ID: 19574023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.